Microbial genome sequencing.

C M Fraser; J A Eisen; S L Salzberg

doi:10.1038/35021244

Home/Archive/PubMed

PubMed · 10963611

Microbial genome sequencing.

C M Fraser·J A Eisen·S L Salzberg

View original source ↗Export metadata ↓

Abstract

Complete genome sequences of 30 microbial species have been determined during the past five years, and work in progress indicates that the complete sequences of more than 100 further microbial species will be available in the next two to four years. These results have revealed a tremendous amount of information on the physiology and evolution of microbial species, and should provide novel approaches to the diagnosis and treatment of infectious disease.

Explore related subjects

Anti-Infective Agents Bacterial Vaccines Drug Design Genome, Bacterial Sequence Analysis, DNA Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

C M Fraser, J A Eisen, S L Salzberg. 2000-08-17. Microbial genome sequencing.. https://doi.org/10.1038/35021244

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Palladium-catalyzed arylation of allylic benzoates using hypervalent siloxane derivatives.

Palladium-catalyzed cross-coupling of hypervalent arylsiloxane derivatives proceeded in good to excellent yields with allylic benzoates. Arylation occurred with complete inversion of configuration. The scope and limitations of this reaction, an alternative to the Stille coupling, is summarized.

Anti-Infective Agents↗

PubMed2001

Moxifloxacin does increase the corrected QT interval.

Explore the source record for details and available documents.

Anti-Infective Agents↗

PubMed2001

Whither infectious diseases consultations? Analysis of 14,005 consultations from a 5-year period.

During a 5-year period, data from all infectious disease (ID) consultations were recorded in a computerized database, which included 9068 new and 4937 additional consultations. The purpose of these 14,005 consultations was therapy (for 58%), diagnosis (for 13%), both (for 24%), and prophylaxis (for 4%); 51% were performed at the bedside, and the remainder were by discussion (19%) or telephone (30%). Recommendations included the following: initiation, change, or discontinuation of antibiotics (in 46%); performance of diagnostic tests (in 20%) or surgical procedures (in 1%); prophylaxis (in 3%); or no change (in 29%). Analysis of new versus additional consultations revealed significant differences. A new ID consultation was given at a rate of 6.0 consultations per 100 hospitalized patients; the rate per department correlated with the expenditure on antimicrobials per patient admission. During the study period, expenditure on antimicrobials per admission steadily decreased, from $44 in 1995 to $30 in 1999, a 35% reduction. In conclusion, analysis of data from ID consultations enables the ID service to evaluate its activity and to direct efforts to departments with high rates of nosocomial infections, antimicrobial resistance, and/or antimicrobial use.

Anti-Infective Agents↗